Chemotherapy could make breast cancer patients more vulnerable to common infectionsBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i407 (Published 26 January 2016) Cite this as: BMJ 2016;352:i407
- Jacqui Wise
Patients with breast cancer who are treated with chemotherapy have depleted immune systems, leaving them vulnerable to common infections, researchers have warned in the journal Breast Cancer Research.1 They said that revaccination against common immunogens may need to be considered in some cases.
Researchers from the University of Leeds measured the levels of lymphocytes and antibodies in 88 women with breast cancer, before chemotherapy and at intervals for nine months after completing chemotherapy. No …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial